Humacyte (HUMA) Stock Gains Pre-Market Momentum Following FDA Nod
Fahim Awan
December 20, 2024
Following a major regulatory approval, Humacyte, Inc.’s (NASDAQ: HUMA) shares surged 68.50% to $5.83 as of the last check during the pre-market trading session. The